{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:29:34Z","timestamp":1790911774442,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T00:00:00Z","timestamp":1279756800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1038\/hr.2010.112","type":"journal-article","created":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T06:04:03Z","timestamp":1279778643000},"page":"965-973","source":"Crossref","is-referenced-by-count":22,"title":["Beneficial effects of a combination of Rho-kinase inhibitor and ACE inhibitor on tubulointerstitial fibrosis induced by unilateral ureteral obstruction"],"prefix":"10.1038","volume":"33","author":[{"given":"Yosuke","family":"Takeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Nishikimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Akimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Ishimitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,22]]},"reference":[{"key":"BFhr2010112_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1152\/physrev.2001.81.1.153","volume":"81","author":"Y Takai","year":"2001","unstructured":"Takai Y, Sasaki T, Matozaki T . Small GTP-binding proteins. Physiol Rev 2001; 81: 153\u2013208.","journal-title":"Physiol Rev"},{"key":"BFhr2010112_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0165-6147(00)01596-0","volume":"22","author":"Y Fukata","year":"2001","unstructured":"Fukata Y, Amano M, Kaibuchi K . Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 2001; 22: 32\u201339.","journal-title":"Trends Pharmacol Sci"},{"key":"BFhr2010112_CR3","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/40187","volume":"389","author":"M Uehata","year":"1997","unstructured":"Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S . Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997; 389: 990\u2013994.","journal-title":"Nature"},{"key":"BFhr2010112_CR4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/00005344-200211000-00013","volume":"40","author":"H Shimokawa","year":"2002","unstructured":"Shimokawa H, Hiramori K, Iinuma H, Hosoda S, Kishida H, Osada H, Katagiri T, Yamauchi K, Yui Y, Minamino T, Nakashima M, Kato K . Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study. J Cardiovasc Pharmacol 2002; 40: 751\u2013761.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFhr2010112_CR5","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1161\/01.ATV.0000176193.83629.c8","volume":"25","author":"H Shimokawa","year":"2005","unstructured":"Shimokawa H, Takeshita A . Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol 2005; 25: 1767\u20131775.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFhr2010112_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1254\/jphs.FMJ05003X5","volume":"100","author":"T Nishikimi","year":"2006","unstructured":"Nishikimi T, Matsuoka H . Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effect of rho-kinase inhibitor in hypertensive glomerulosclerosis. J Pharmacol Sci 2006; 100: 22\u201328.","journal-title":"J Pharmacol Sci"},{"key":"BFhr2010112_CR7","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1046\/j.1523-1755.2002.00328.x","volume":"61","author":"K Nagatoya","year":"2002","unstructured":"Nagatoya K, Moriyama T, Kawada N, Takeji M, Oseto S, Murozono T, Ando A, Imai E, Hori M . Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int 2002; 61: 1684\u20131695.","journal-title":"Kidney Int"},{"key":"BFhr2010112_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0014-2999(02)02619-5","volume":"455","author":"S Satoh","year":"2002","unstructured":"Satoh S, Yamaguchi T, Hitomi A, Sato N, Shiraiwa K, Ikegaki I, Asano T, Shimokawa H . Fasudil attenuates interstitial fibrosis in rat kidneys with unilateral ureteral obstruction. Eur J Pharmacol 2002; 455: 169\u2013174.","journal-title":"Eur J Pharmacol"},{"key":"BFhr2010112_CR9","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1097\/00004872-200409000-00024","volume":"22","author":"T Nishikimi","year":"2004","unstructured":"Nishikimi T, Akimoto K, Wang X, Mori Y, Tadokoro K, Ishikawa Y, Shimokawa H, Ono H, Matsuoka H . Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats. J Hypertens 2004; 22: 1787\u20131796.","journal-title":"J Hypertens"},{"key":"BFhr2010112_CR10","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1046\/j.1523-1755.2003.00300.x","volume":"64","author":"T Kanda","year":"2003","unstructured":"Kanda T, Wakino S, Hayashi K, Homma K, Ozawa Y, Saruta T . Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats. Kidney Int 2003; 64: 2009\u20132019.","journal-title":"Kidney Int"},{"key":"BFhr2010112_CR11","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1161\/01.HYP.0000221605.94532.71","volume":"47","author":"Y Ishikawa","year":"2006","unstructured":"Ishikawa Y, Nishikimi T, Akimoto K, Ishimura K, Ono H, Matsuoka H . Long-term administration of rho-kinase inhibitor ameliorates renal damage in malignant hypertensive rats. Hypertension 2006; 47: 1075\u20131083.","journal-title":"Hypertension"},{"key":"BFhr2010112_CR12","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/HJH.0b013e3280825440","volume":"25","author":"T Nishikimi","year":"2007","unstructured":"Nishikimi T, Koshikawa S, Ishikawa Y, Akimoto K, Inaba C, Ishimura K, Ono H, Matsuoka H . Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats. J Hypertens 2007; 25: 1053\u20131063.","journal-title":"J Hypertens"},{"key":"BFhr2010112_CR13","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1681\/ASN.2005121375","volume":"17","author":"GP Sun","year":"2006","unstructured":"Sun GP, Kohno M, Guo P, Nagai Y, Miyata K, Fan YY, Kimura S, Kiyomoto H, Ohmori K, Li DT, Abe Y, Nishiyama A . Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury. J Am Soc Nephrol 2006; 17: 2193\u20132201.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr2010112_CR14","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.2337\/db07-1149","volume":"57","author":"F Peng","year":"2008","unstructured":"Peng F, Wu D, Gao B, Ingram AJ, Zhang B, Chorneyko K, McKenzie R, Krepinsky JC . RhoA\/Rho-kinase contribute to the pathogenesis of diabetic renal disease. Diabetes 2008; 57: 1683\u20131692.","journal-title":"Diabetes"},{"key":"BFhr2010112_CR15","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1097\/HJH.0b013e328305086c","volume":"26","author":"S Koshikawa","year":"2008","unstructured":"Koshikawa S, Nishikimi T, Inaba C, Akimoto K, Matsuoka H . Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats. J Hypertens 2008; 26: 1837\u20131848.","journal-title":"J Hypertens"},{"key":"BFhr2010112_CR16","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1097\/01.hjh.0000125458.28861.49","volume":"22","author":"H Ono","year":"2004","unstructured":"Ono H, Saitoh M, Ono Y, Ishimitu T, Matsuoka H . Imidapril improves L-NAME-exacerbated nephrosclerosis with TGF-beta 1 inhibition in spontaneously hypertensive rats. J Hypertens 2004; 22: 1389\u20131395.","journal-title":"J Hypertens"},{"key":"BFhr2010112_CR17","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/ki.2008.511","volume":"111","author":"P Cravedi","year":"2008","unstructured":"Cravedi P, Remuzzi G . Treating the kidney to cure the heart. Kidney Int Suppl 2008; 111: S2\u2013S3.","journal-title":"Kidney Int Suppl"},{"key":"BFhr2010112_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.regpep.2009.02.006","volume":"154","author":"T Nishikimi","year":"2009","unstructured":"Nishikimi T, Inaba-Iemura C, Ishimura K, Tadokoro K, Koshikawa S, Ishikawa K, Akimoto K, Hattori Y, Kasai K, Minamino N, Maeda N, Matsuoka H . Peptide\/natriuretic peptide receptor-A (NPR-A) system has inhibitory effects in renal fibrosis in mice. Regul Pept 2009; 154: 44\u201353.","journal-title":"Regul Pept"},{"key":"BFhr2010112_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1161\/01.RES.0000096650.91688.28","volume":"93","author":"M Higashi","year":"2003","unstructured":"Higashi M, Shimokawa H, Hattori T, Hiroki J, Mukai Y, Morikawa K, Ichiki T, Takahashi S, Takeshita A . Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ Res 2003; 93: 767\u2013775.","journal-title":"Circ Res"},{"key":"BFhr2010112_CR20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cardiores.2004.12.014","volume":"66","author":"T Nishikimi","year":"2005","unstructured":"Nishikimi T, Hagaman JR, Takahashi N, Kim HS, Matsuoka H, Smithies O, Maeda N . Susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene. Cardiovasc Res 2005; 66: 94\u2013103.","journal-title":"Cardiovasc Res"},{"key":"BFhr2010112_CR21","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/ki.2009.86","volume":"75","author":"RL Chevalier","year":"2009","unstructured":"Chevalier RL, Forbes MS, Thornhill BA . Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 2009; 75: 1145\u20131152.","journal-title":"Kidney Int"},{"key":"BFhr2010112_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/sj.ki.5002325","volume":"72","author":"T Wada","year":"2007","unstructured":"Wada T, Sakai N, Matsushima K, Kaneko S . Fibrocytes: a new insight into kidney fibrosis. Kidney Int 2007; 72: 269\u2013273.","journal-title":"Kidney Int"},{"key":"BFhr2010112_CR23","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1523-1755.2005.00486.x","volume":"68","author":"JL Bascands","year":"2005","unstructured":"Bascands JL, Schanstra JP . Obstructive nephropathy: insights from genetically engineered animals. Kidney Int 2005; 68: 925\u2013937.","journal-title":"Kidney Int"},{"key":"BFhr2010112_CR24","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/ki.2009.86","volume":"75","author":"RL Chevalier","year":"2009","unstructured":"Chevalier RL, Forbes MS, Thornhill BA . Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 2009; 75: 1145\u20131152.","journal-title":"Kidney Int"},{"key":"BFhr2010112_CR25","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1172\/JCI200319270","volume":"112","author":"M Sato","year":"2003","unstructured":"Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A . Targeted disruption of TGF-beta1\/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 2003; 112: 1486\u20131494.","journal-title":"J Clin Invest"},{"key":"BFhr2010112_CR26","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ki.1988.207","volume":"34","author":"GF Schreiner","year":"1988","unstructured":"Schreiner GF, Harris KP, Purkerson ML, Klahr S . Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. Kidney Int 1988; 34: 487\u2013493.","journal-title":"Kidney Int"},{"key":"BFhr2010112_CR27","first-page":"F926","volume":"266","author":"JR Diamond","year":"1994","unstructured":"Diamond JR, Kees-Folts D, Ding G, Frye JE, Restrepo NC . Macrophages, monocyte chemoattractant peptide-1, and TGF-beta 1 in experimental hydronephrosis. Am J Physiol 1994; 266: F926\u2013F933.","journal-title":"Am J Physiol"},{"key":"BFhr2010112_CR28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000256659","volume":"31","author":"CE Hills","year":"2010","unstructured":"Hills CE, Squires PE . TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. Am J Nephrol 2010; 31: 68\u201374.","journal-title":"Am J Nephrol"},{"key":"BFhr2010112_CR29","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/nm888","volume":"9","author":"M Zeisberg","year":"2003","unstructured":"Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R . BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003; 9: 964\u2013968.","journal-title":"Nat Med"},{"key":"BFhr2010112_CR30","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1038\/ki.2008.516","volume":"111","author":"V Cachofeiro","year":"2008","unstructured":"Cachofeiro V, Goicochea M, de Vinuesa SG, Oubia P, Lahera V, Luo J . Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl 2008; 111: S4\u2013S9.","journal-title":"Kidney Int Suppl"},{"key":"BFhr2010112_CR31","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1517\/14728222.11.8.1011","volume":"11","author":"A Tojo","year":"2007","unstructured":"Tojo A, Asaba K, Onozato ML . Suppressing renal NADPH oxidase to treat diabetic nephropathy. Expert Opin Ther Targets 2007; 11: 1011\u20131018.","journal-title":"Expert Opin Ther Targets"},{"issue":"Suppl 2","key":"BFhr2010112_CR32","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.2337\/dc08-s247","volume":"31","author":"TM Paravicini","year":"2008","unstructured":"Paravicini TM, Touyz RM . NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 2008; 31 (Suppl 2): S170\u2013S180.","journal-title":"Diabetes Care"},{"key":"BFhr2010112_CR33","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1093\/ndt\/gfi045","volume":"20","author":"H Sugiyama","year":"2005","unstructured":"Sugiyama H, Kobayashi M, Wang DH, Sunami R, Maeshima Y, Yamasaki Y, Masuoka N, Kira S, Makino H . Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice. Nephrol Dial Transplant 2005; 20: 2670\u20132680.","journal-title":"Nephrol Dial Transplant"},{"key":"BFhr2010112_CR34","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1517\/14728222.11.8.1011","volume":"11","author":"A Tojo","year":"2007","unstructured":"Tojo A, Asaba K, Onozato ML . Suppressing renal NADPH oxidase to treat diabetic nephropathy. Expert Opin Ther Targets 2007; 11: 1011\u20131018.","journal-title":"Expert Opin Ther Targets"},{"key":"BFhr2010112_CR35","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1111\/j.1523-1755.2005.00675.x","volume":"68","author":"CM Ferrario","year":"2005","unstructured":"Ferrario CM, Jessup J, Gallagher PE, Averill DB, Brosnihan KB, Ann Tallant E, Smith RD, Chappell MC . Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors. Kidney Int 2005; 68: 2189\u20132196.","journal-title":"Kidney Int"},{"key":"BFhr2010112_CR36","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1056\/NEJM199811123392007","volume":"339","author":"G Remuzzi","year":"1998","unstructured":"Remuzzi G, Bertani T . Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339: 1448\u20131456.","journal-title":"N Engl J Med"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr2010112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2010112","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2010112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:05:24Z","timestamp":1684429524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr2010112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,22]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["BFhr2010112"],"URL":"https:\/\/doi.org\/10.1038\/hr.2010.112","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,22]]}}}